Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Billionaire hedge fund manager Bill Ackman increased his bets by fivefold in Nike (NKE), suggesting potential changes to ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Elon Musk’s artificial intelligence company xAI is raising up to $6 billion at a $50 billion valuation, according to CNBC’s ...

The expanded services help customers receive consultations and medications for erectile dysfunction, men’s hair loss, eyelash growth, motion sickness, and anti-aging skin care.

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Here are five key things investors need to know to start the trading day: Stocks moved lower Thursday, as the Dow Jones ...

Chinese e-commerce behemoth Alibaba on Friday beat profit expectations in its September quarter, citing an acceleration in ...

NHTSA slaps Ford with $165M fine for failing to timely issue recall. GM's Cruise to pay $500,000 fine for false report on car ...

Hims & Hers Health ( HIMS, Financials) shares slumped 24.5% on Thursday as Amazon ( AMZN, Financials) expanded into hair loss ...

Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...

Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel ...